(Q35907056)

11 August 2017

1 reference

title

Oncolytic measles viruses for cancer therapy (English)

1 reference

11 August 2017

1 reference

1 reference

2

Stephen J Russell

1 reference

11 August 2017

Takafumi Nakamura

1

1 reference

PubMed ID

15461580

11 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

Expert Opinion on Biological Therapy

11 August 2017

1 reference

11 August 2017

4

1 reference

11 August 2017

1685-1692

1 reference

11 August 2017

10

1 reference

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

11 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

RNA viruses as virotherapy agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

SLAM (CDw150) is a cellular receptor for measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Induction of the measles virus receptor SLAM (CD150) on monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Regression of Burkitt's lymphoma in association with measles infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Systemic therapy of myeloma xenografts by an attenuated measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

The cellular receptor for measles virus--elusive no more

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Complement resistance of tumor cells: basal and induced mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Distinct kinetics for binding of the CD46 and SLAM receptors to overlapping sites in the measles virus hemagglutinin protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Viruses and interferon: a fight for supremacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Reovirus as a novel oncolytic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Oncolytic herpes simplex virus vectors for cancer virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Membrane cofactor protein (MCP; CD46) expression in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Model Systems: transgenic mouse models for measles pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Biodistribution of Oncolytic Measles Virus After Intraperitoneal Administration into Ifnar™-CD46Ge Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

An immunohistochemical study of the distribution of the measles virus receptors, CD46 and SLAM, in normal human tissues and subacute sclerosing panencephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Measles virus-induced promotion of dendritic cell maturation by soluble mediators does not overcome the immunosuppressive activity of viral glycoproteins on the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Structural and functional studies of the measles virus hemagglutinin: identification of a novel site required for CD46 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Antibody-targeted cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1685

10.1517/14712598.4.10.1685

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15461580